Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
12
SHWGY Quote, Financials, Valuation and Earnings
Last price:
$2.54
Seasonality move
:
-2.37%
Day range:
$2.54 - $2.54
52-week range:
$2.06 - $3.51
Dividend yield:
4.84%
P/E ratio:
10.64x
P/S ratio:
1.60x
P/B ratio:
4.53x
Volume:
--
Avg. volume:
68
1-year change:
5.18%
Market cap:
$2.8B
Revenue:
$1.8B
EPS (TTM):
$0.24
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Shandong Weigao Group Medical Polymer Co. Ltd. has -- downside to fair value with a price target of -- per share.
SHWGY vs. S&P 500
-
Over the past 5 trading days, Shandong Weigao Group Medical Polymer Co. Ltd. has overperformed the S&P 500 by 0.78% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Shandong Weigao Group Medical Polymer Co. Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Shandong Weigao Group Medical Polymer Co. Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Shandong Weigao Group Medical Polymer Co. Ltd. reported revenues of --.
Earnings Growth
-
Shandong Weigao Group Medical Polymer Co. Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Shandong Weigao Group Medical Polymer Co. Ltd. reported earnings per share of --.
Enterprise value:
2.4B
EV / Invested capital:
--
Price / LTM sales:
1.60x
EV / EBIT:
7.77x
EV / Revenue:
1.32x
PEG ratio (5yr expected):
--
EV / Free cash flow:
7.17x
Price / Operating cash flow:
8.67x
Enterprise value / EBITDA:
5.37x
Gross Profit (TTM):
$859.9M
Return On Assets:
6.04%
Net Income Margin (TTM):
15.78%
Return On Equity:
8.41%
Return On Invested Capital:
7.23%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-06-30 | 2013-06-30 | 2014-06-30 | 2013-06-30 | 2014-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $186.8M | $220.9M | |
| Gross Profit | -- | -- | $242.4M | $110.3M | $130.4M | |
| Operating Income | -- | -- | -- | $42.3M | $45.9M | |
| EBITDA | -- | -- | -- | $48.8M | $49.7M | |
| Diluted EPS | -- | $0.38 | $0.23 | $0.03 | $0.04 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $2.6B | $2.6B | $2.7B | -- | |
| Total Assets | $4.6B | $4.9B | $4.7B | $4.8B | -- | |
| Current Liabilities | $863.6M | $881.4M | $910.3M | $819.9M | -- | |
| Total Liabilities | $1.5B | $1.5B | $1.4B | $1.4B | -- | |
| Total Equity | $3.1B | $3.3B | $3.3B | $3.4B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-06-30 | 2013-06-30 | 2014-06-30 | 2013-06-30 | 2014-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $44.2M | $55.5M | |
| Cash From Investing | -- | -- | -- | -$78.4M | -$54.7M | |
| Cash From Financing | -- | -- | -- | $34M | -$23M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SHWGY
Sector
Market Cap
$2.8B
$28.1M
Price % of 52-Week High
72.37%
51.42%
Dividend Yield
4.84%
0%
Shareholder Yield
6.54%
-1.45%
1-Year Price Total Return
5.18%
-19.74%
Beta (5-Year)
0.059
0.516
Dividend yield:
4.84%
Annualized payout:
$0.10
Payout ratio:
--
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$2.58
200-day SMA
Sell
Level
$2.98
Bollinger Bands (100)
Sell
Level
2.67 - 3.41
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$2.56
Relative Strength Index (RSI14)
Sell
Level
34.93
ADX Line
Neutral
Level
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$2.74
MACD (12, 26)
Buy
Level
0.36
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.142)
Buy
CA Score
(Annual)
Level (0.7976)
Buy
Beneish M-Score
(Annual)
Level (-2.5119)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.7387)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
Stock Forecast FAQ
In the current month, SHWGY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SHWGY average analyst price target in the past 3 months is --.
-
Where Will Shandong Weigao Group Medical Polymer Co. Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Shandong Weigao Group Medical Polymer Co. Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Shandong Weigao Group Medical Polymer Co. Ltd.?
Analysts are divided on their view about Shandong Weigao Group Medical Polymer Co. Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Shandong Weigao Group Medical Polymer Co. Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Shandong Weigao Group Medical Polymer Co. Ltd.'s Price Target?
The price target for Shandong Weigao Group Medical Polymer Co. Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SHWGY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Shandong Weigao Group Medical Polymer Co. Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SHWGY?
You can purchase shares of Shandong Weigao Group Medical Polymer Co. Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Shandong Weigao Group Medical Polymer Co. Ltd. shares.
-
What Is The Shandong Weigao Group Medical Polymer Co. Ltd. Share Price Today?
Shandong Weigao Group Medical Polymer Co. Ltd. was last trading at $2.54 per share. This represents the most recent stock quote for Shandong Weigao Group Medical Polymer Co. Ltd.. Yesterday, Shandong Weigao Group Medical Polymer Co. Ltd. closed at $2.54 per share.
-
How To Buy Shandong Weigao Group Medical Polymer Co. Ltd. Stock Online?
In order to purchase Shandong Weigao Group Medical Polymer Co. Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SHWGY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHWGY
Sector
P/E ratio
10.64x
23.98x
PEG ratio
--
-0.01x
P/B ratio
4.53x
1.81x
Price / LTM sales
1.60x
1.60x
Growth Metrics
SHWGY
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.88%
Revenue (5-year growth)
3.89%
6.5%
Earnings forecast
--
-$0.20
Profitability
SHWGY
Sector
Profitability FY 2024
$874.4M
$3.6M
Return on invested capital
7.23%
-31.84%
Return on assets
6.04%
-27.89%
Return on equity
8.41%
-37.47%
Earnings Date
Last Earnings Date
Aug
27
Next Earnings Date
Mar
26
Estimated Next Earnings Date
Nov
26
Balance Sheet
SHWGY
Sector
Total cash
$1.1B
$26.6M
Short term investments
$74.2M
$25.7M
Total assets
$4.8B
$78M
Long term debt
--
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 24.85% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is down 19.66% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is down 16.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
